Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Imipenem API Market Growth 2022-2028

  • LP 4832687
  • 113 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Imipenem API will have significant change from previous year. According to our (LP Information) latest study, the global Imipenem API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Imipenem API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Imipenem API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Imipenem API market, reaching US$ million by the year 2028. As for the Europe Imipenem API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Imipenem API players cover Hospira, ACS DOBFAR SPA, High Science, and Jeil Pharmaceutica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Imipenem API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Aseptic API

Non-sterile API

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Intramuscular Injection

Static Drops

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Hospira

ACS DOBFAR SPA

High Science

Jeil Pharmaceutica

Choongwae Pharma Corporation

Sun Pharmaceutical

Sandoz

Kaliberr

Auronext Pharma

Nectar Lifesciences

Savior Lifetec Corporation

Zhuhai United Laboratorie

SUZHOU HOMESUN PHARMACEUTICAL

Unimark Remedies

Zhejiang Haixiang Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Imipenem API Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Imipenem API by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Imipenem API by Country/Region, 2017, 2022 & 2028

2.2 Imipenem API Segment by Type

2.2.1 Aseptic API

2.2.2 Non-sterile API

2.3 Imipenem API Sales by Type

2.3.1 Global Imipenem API Sales Market Share by Type (2017-2022)

2.3.2 Global Imipenem API Revenue and Market Share by Type (2017-2022)

2.3.3 Global Imipenem API Sale Price by Type (2017-2022)

2.4 Imipenem API Segment by Application

2.4.1 Intramuscular Injection

2.4.2 Static Drops

2.5 Imipenem API Sales by Application

2.5.1 Global Imipenem API Sale Market Share by Application (2017-2022)

2.5.2 Global Imipenem API Revenue and Market Share by Application (2017-2022)

2.5.3 Global Imipenem API Sale Price by Application (2017-2022)

3 Global Imipenem API by Company

3.1 Global Imipenem API Breakdown Data by Company

3.1.1 Global Imipenem API Annual Sales by Company (2020-2022)

3.1.2 Global Imipenem API Sales Market Share by Company (2020-2022)

3.2 Global Imipenem API Annual Revenue by Company (2020-2022)

3.2.1 Global Imipenem API Revenue by Company (2020-2022)

3.2.2 Global Imipenem API Revenue Market Share by Company (2020-2022)

3.3 Global Imipenem API Sale Price by Company

3.4 Key Manufacturers Imipenem API Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Imipenem API Product Location Distribution

3.4.2 Players Imipenem API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Imipenem API by Geographic Region

4.1 World Historic Imipenem API Market Size by Geographic Region (2017-2022)

4.1.1 Global Imipenem API Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Imipenem API Annual Revenue by Geographic Region

4.2 World Historic Imipenem API Market Size by Country/Region (2017-2022)

4.2.1 Global Imipenem API Annual Sales by Country/Region (2017-2022)

4.2.2 Global Imipenem API Annual Revenue by Country/Region

4.3 Americas Imipenem API Sales Growth

4.4 APAC Imipenem API Sales Growth

4.5 Europe Imipenem API Sales Growth

4.6 Middle East & Africa Imipenem API Sales Growth

5 Americas

5.1 Americas Imipenem API Sales by Country

5.1.1 Americas Imipenem API Sales by Country (2017-2022)

5.1.2 Americas Imipenem API Revenue by Country (2017-2022)

5.2 Americas Imipenem API Sales by Type

5.3 Americas Imipenem API Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Imipenem API Sales by Region

6.1.1 APAC Imipenem API Sales by Region (2017-2022)

6.1.2 APAC Imipenem API Revenue by Region (2017-2022)

6.2 APAC Imipenem API Sales by Type

6.3 APAC Imipenem API Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Imipenem API by Country

7.1.1 Europe Imipenem API Sales by Country (2017-2022)

7.1.2 Europe Imipenem API Revenue by Country (2017-2022)

7.2 Europe Imipenem API Sales by Type

7.3 Europe Imipenem API Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Imipenem API by Country

8.1.1 Middle East & Africa Imipenem API Sales by Country (2017-2022)

8.1.2 Middle East & Africa Imipenem API Revenue by Country (2017-2022)

8.2 Middle East & Africa Imipenem API Sales by Type

8.3 Middle East & Africa Imipenem API Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Imipenem API

10.3 Manufacturing Process Analysis of Imipenem API

10.4 Industry Chain Structure of Imipenem API

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Imipenem API Distributors

11.3 Imipenem API Customer

12 World Forecast Review for Imipenem API by Geographic Region

12.1 Global Imipenem API Market Size Forecast by Region

12.1.1 Global Imipenem API Forecast by Region (2023-2028)

12.1.2 Global Imipenem API Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Imipenem API Forecast by Type

12.7 Global Imipenem API Forecast by Application

13 Key Players Analysis

13.1 Hospira

13.1.1 Hospira Company Information

13.1.2 Hospira Imipenem API Product Offered

13.1.3 Hospira Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hospira Main Business Overview

13.1.5 Hospira Latest Developments

13.2 ACS DOBFAR SPA

13.2.1 ACS DOBFAR SPA Company Information

13.2.2 ACS DOBFAR SPA Imipenem API Product Offered

13.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 ACS DOBFAR SPA Main Business Overview

13.2.5 ACS DOBFAR SPA Latest Developments

13.3 High Science

13.3.1 High Science Company Information

13.3.2 High Science Imipenem API Product Offered

13.3.3 High Science Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 High Science Main Business Overview

13.3.5 High Science Latest Developments

13.4 Jeil Pharmaceutica

13.4.1 Jeil Pharmaceutica Company Information

13.4.2 Jeil Pharmaceutica Imipenem API Product Offered

13.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Jeil Pharmaceutica Main Business Overview

13.4.5 Jeil Pharmaceutica Latest Developments

13.5 Choongwae Pharma Corporation

13.5.1 Choongwae Pharma Corporation Company Information

13.5.2 Choongwae Pharma Corporation Imipenem API Product Offered

13.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Choongwae Pharma Corporation Main Business Overview

13.5.5 Choongwae Pharma Corporation Latest Developments

13.6 Sun Pharmaceutical

13.6.1 Sun Pharmaceutical Company Information

13.6.2 Sun Pharmaceutical Imipenem API Product Offered

13.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sun Pharmaceutical Main Business Overview

13.6.5 Sun Pharmaceutical Latest Developments

13.7 Sandoz

13.7.1 Sandoz Company Information

13.7.2 Sandoz Imipenem API Product Offered

13.7.3 Sandoz Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sandoz Main Business Overview

13.7.5 Sandoz Latest Developments

13.8 Kaliberr

13.8.1 Kaliberr Company Information

13.8.2 Kaliberr Imipenem API Product Offered

13.8.3 Kaliberr Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kaliberr Main Business Overview

13.8.5 Kaliberr Latest Developments

13.9 Auronext Pharma

13.9.1 Auronext Pharma Company Information

13.9.2 Auronext Pharma Imipenem API Product Offered

13.9.3 Auronext Pharma Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Auronext Pharma Main Business Overview

13.9.5 Auronext Pharma Latest Developments

13.10 Nectar Lifesciences

13.10.1 Nectar Lifesciences Company Information

13.10.2 Nectar Lifesciences Imipenem API Product Offered

13.10.3 Nectar Lifesciences Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Nectar Lifesciences Main Business Overview

13.10.5 Nectar Lifesciences Latest Developments

13.11 Savior Lifetec Corporation

13.11.1 Savior Lifetec Corporation Company Information

13.11.2 Savior Lifetec Corporation Imipenem API Product Offered

13.11.3 Savior Lifetec Corporation Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Savior Lifetec Corporation Main Business Overview

13.11.5 Savior Lifetec Corporation Latest Developments

13.12 Zhuhai United Laboratorie

13.12.1 Zhuhai United Laboratorie Company Information

13.12.2 Zhuhai United Laboratorie Imipenem API Product Offered

13.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Zhuhai United Laboratorie Main Business Overview

13.12.5 Zhuhai United Laboratorie Latest Developments

13.13 SUZHOU HOMESUN PHARMACEUTICAL

13.13.1 SUZHOU HOMESUN PHARMACEUTICAL Company Information

13.13.2 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product Offered

13.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 SUZHOU HOMESUN PHARMACEUTICAL Main Business Overview

13.13.5 SUZHOU HOMESUN PHARMACEUTICAL Latest Developments

13.14 Unimark Remedies

13.14.1 Unimark Remedies Company Information

13.14.2 Unimark Remedies Imipenem API Product Offered

13.14.3 Unimark Remedies Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Unimark Remedies Main Business Overview

13.14.5 Unimark Remedies Latest Developments

13.15 Zhejiang Haixiang Pharmaceutical

13.15.1 Zhejiang Haixiang Pharmaceutical Company Information

13.15.2 Zhejiang Haixiang Pharmaceutical Imipenem API Product Offered

13.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Zhejiang Haixiang Pharmaceutical Main Business Overview

13.15.5 Zhejiang Haixiang Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Imipenem API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Imipenem API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Aseptic API

Table 4. Major Players of Non-sterile API

Table 5. Global Imipenem API Sales by Type (2017-2022) & (KG)

Table 6. Global Imipenem API Sales Market Share by Type (2017-2022)

Table 7. Global Imipenem API Revenue by Type (2017-2022) & ($ million)

Table 8. Global Imipenem API Revenue Market Share by Type (2017-2022)

Table 9. Global Imipenem API Sale Price by Type (2017-2022) & (US$/G)

Table 10. Global Imipenem API Sales by Application (2017-2022) & (KG)

Table 11. Global Imipenem API Sales Market Share by Application (2017-2022)

Table 12. Global Imipenem API Revenue by Application (2017-2022)

Table 13. Global Imipenem API Revenue Market Share by Application (2017-2022)

Table 14. Global Imipenem API Sale Price by Application (2017-2022) & (US$/G)

Table 15. Global Imipenem API Sales by Company (2020-2022) & (KG)

Table 16. Global Imipenem API Sales Market Share by Company (2020-2022)

Table 17. Global Imipenem API Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Imipenem API Revenue Market Share by Company (2020-2022)

Table 19. Global Imipenem API Sale Price by Company (2020-2022) & (US$/G)

Table 20. Key Manufacturers Imipenem API Producing Area Distribution and Sales Area

Table 21. Players Imipenem API Products Offered

Table 22. Imipenem API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Imipenem API Sales by Geographic Region (2017-2022) & (KG)

Table 26. Global Imipenem API Sales Market Share Geographic Region (2017-2022)

Table 27. Global Imipenem API Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Imipenem API Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Imipenem API Sales by Country/Region (2017-2022) & (KG)

Table 30. Global Imipenem API Sales Market Share by Country/Region (2017-2022)

Table 31. Global Imipenem API Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Imipenem API Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Imipenem API Sales by Country (2017-2022) & (KG)

Table 34. Americas Imipenem API Sales Market Share by Country (2017-2022)

Table 35. Americas Imipenem API Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Imipenem API Revenue Market Share by Country (2017-2022)

Table 37. Americas Imipenem API Sales by Type (2017-2022) & (KG)

Table 38. Americas Imipenem API Sales Market Share by Type (2017-2022)

Table 39. Americas Imipenem API Sales by Application (2017-2022) & (KG)

Table 40. Americas Imipenem API Sales Market Share by Application (2017-2022)

Table 41. APAC Imipenem API Sales by Region (2017-2022) & (KG)

Table 42. APAC Imipenem API Sales Market Share by Region (2017-2022)

Table 43. APAC Imipenem API Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Imipenem API Revenue Market Share by Region (2017-2022)

Table 45. APAC Imipenem API Sales by Type (2017-2022) & (KG)

Table 46. APAC Imipenem API Sales Market Share by Type (2017-2022)

Table 47. APAC Imipenem API Sales by Application (2017-2022) & (KG)

Table 48. APAC Imipenem API Sales Market Share by Application (2017-2022)

Table 49. Europe Imipenem API Sales by Country (2017-2022) & (KG)

Table 50. Europe Imipenem API Sales Market Share by Country (2017-2022)

Table 51. Europe Imipenem API Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Imipenem API Revenue Market Share by Country (2017-2022)

Table 53. Europe Imipenem API Sales by Type (2017-2022) & (KG)

Table 54. Europe Imipenem API Sales Market Share by Type (2017-2022)

Table 55. Europe Imipenem API Sales by Application (2017-2022) & (KG)

Table 56. Europe Imipenem API Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Imipenem API Sales by Country (2017-2022) & (KG)

Table 58. Middle East & Africa Imipenem API Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Imipenem API Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Imipenem API Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Imipenem API Sales by Type (2017-2022) & (KG)

Table 62. Middle East & Africa Imipenem API Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Imipenem API Sales by Application (2017-2022) & (KG)

Table 64. Middle East & Africa Imipenem API Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Imipenem API

Table 66. Key Market Challenges & Risks of Imipenem API

Table 67. Key Industry Trends of Imipenem API

Table 68. Imipenem API Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Imipenem API Distributors List

Table 71. Imipenem API Customer List

Table 72. Global Imipenem API Sales Forecast by Region (2023-2028) & (KG)

Table 73. Global Imipenem API Sales Market Forecast by Region

Table 74. Global Imipenem API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Imipenem API Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Imipenem API Sales Forecast by Country (2023-2028) & (KG)

Table 77. Americas Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Imipenem API Sales Forecast by Region (2023-2028) & (KG)

Table 79. APAC Imipenem API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Imipenem API Sales Forecast by Country (2023-2028) & (KG)

Table 81. Europe Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Imipenem API Sales Forecast by Country (2023-2028) & (KG)

Table 83. Middle East & Africa Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Imipenem API Sales Forecast by Type (2023-2028) & (KG)

Table 85. Global Imipenem API Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Imipenem API Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Imipenem API Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Imipenem API Sales Forecast by Application (2023-2028) & (KG)

Table 89. Global Imipenem API Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Imipenem API Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Imipenem API Revenue Market Share Forecast by Application (2023-2028)

Table 92. Hospira Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 93. Hospira Imipenem API Product Offered

Table 94. Hospira Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 95. Hospira Main Business

Table 96. Hospira Latest Developments

Table 97. ACS DOBFAR SPA Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 98. ACS DOBFAR SPA Imipenem API Product Offered

Table 99. ACS DOBFAR SPA Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 100. ACS DOBFAR SPA Main Business

Table 101. ACS DOBFAR SPA Latest Developments

Table 102. High Science Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 103. High Science Imipenem API Product Offered

Table 104. High Science Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 105. High Science Main Business

Table 106. High Science Latest Developments

Table 107. Jeil Pharmaceutica Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 108. Jeil Pharmaceutica Imipenem API Product Offered

Table 109. Jeil Pharmaceutica Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 110. Jeil Pharmaceutica Main Business

Table 111. Jeil Pharmaceutica Latest Developments

Table 112. Choongwae Pharma Corporation Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 113. Choongwae Pharma Corporation Imipenem API Product Offered

Table 114. Choongwae Pharma Corporation Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 115. Choongwae Pharma Corporation Main Business

Table 116. Choongwae Pharma Corporation Latest Developments

Table 117. Sun Pharmaceutical Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 118. Sun Pharmaceutical Imipenem API Product Offered

Table 119. Sun Pharmaceutical Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 120. Sun Pharmaceutical Main Business

Table 121. Sun Pharmaceutical Latest Developments

Table 122. Sandoz Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 123. Sandoz Imipenem API Product Offered

Table 124. Sandoz Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 125. Sandoz Main Business

Table 126. Sandoz Latest Developments

Table 127. Kaliberr Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 128. Kaliberr Imipenem API Product Offered

Table 129. Kaliberr Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 130. Kaliberr Main Business

Table 131. Kaliberr Latest Developments

Table 132. Auronext Pharma Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 133. Auronext Pharma Imipenem API Product Offered

Table 134. Auronext Pharma Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 135. Auronext Pharma Main Business

Table 136. Auronext Pharma Latest Developments

Table 137. Nectar Lifesciences Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 138. Nectar Lifesciences Imipenem API Product Offered

Table 139. Nectar Lifesciences Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 140. Nectar Lifesciences Main Business

Table 141. Nectar Lifesciences Latest Developments

Table 142. Savior Lifetec Corporation Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 143. Savior Lifetec Corporation Imipenem API Product Offered

Table 144. Savior Lifetec Corporation Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 145. Savior Lifetec Corporation Main Business

Table 146. Savior Lifetec Corporation Latest Developments

Table 147. Zhuhai United Laboratorie Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 148. Zhuhai United Laboratorie Imipenem API Product Offered

Table 149. Zhuhai United Laboratorie Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 150. Zhuhai United Laboratorie Main Business

Table 151. Zhuhai United Laboratorie Latest Developments

Table 152. SUZHOU HOMESUN PHARMACEUTICAL Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 153. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product Offered

Table 154. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 155. SUZHOU HOMESUN PHARMACEUTICAL Main Business

Table 156. SUZHOU HOMESUN PHARMACEUTICAL Latest Developments

Table 157. Unimark Remedies Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 158. Unimark Remedies Imipenem API Product Offered

Table 159. Unimark Remedies Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 160. Unimark Remedies Main Business

Table 161. Unimark Remedies Latest Developments

Table 162. Zhejiang Haixiang Pharmaceutical Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors

Table 163. Zhejiang Haixiang Pharmaceutical Imipenem API Product Offered

Table 164. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 165. Zhejiang Haixiang Pharmaceutical Main Business

Table 166. Zhejiang Haixiang Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Imipenem API

Figure 2. Imipenem API Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Imipenem API Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Imipenem API Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Imipenem API Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Aseptic API

Figure 10. Product Picture of Non-sterile API

Figure 11. Global Imipenem API Sales Market Share by Type in 2021

Figure 12. Global Imipenem API Revenue Market Share by Type (2017-2022)

Figure 13. Imipenem API Consumed in Intramuscular Injection

Figure 14. Global Imipenem API Market: Intramuscular Injection (2017-2022) & (KG)

Figure 15. Imipenem API Consumed in Static Drops

Figure 16. Global Imipenem API Market: Static Drops (2017-2022) & (KG)

Figure 17. Global Imipenem API Sales Market Share by Application (2017-2022)

Figure 18. Global Imipenem API Revenue Market Share by Application in 2021

Figure 19. Imipenem API Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Imipenem API Revenue Market Share by Company in 2021

Figure 21. Global Imipenem API Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Imipenem API Revenue Market Share by Geographic Region in 2021

Figure 23. Global Imipenem API Sales Market Share by Region (2017-2022)

Figure 24. Global Imipenem API Revenue Market Share by Country/Region in 2021

Figure 25. Americas Imipenem API Sales 2017-2022 (KG)

Figure 26. Americas Imipenem API Revenue 2017-2022 ($ Millions)

Figure 27. APAC Imipenem API Sales 2017-2022 (KG)

Figure 28. APAC Imipenem API Revenue 2017-2022 ($ Millions)

Figure 29. Europe Imipenem API Sales 2017-2022 (KG)

Figure 30. Europe Imipenem API Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Imipenem API Sales 2017-2022 (KG)

Figure 32. Middle East & Africa Imipenem API Revenue 2017-2022 ($ Millions)

Figure 33. Americas Imipenem API Sales Market Share by Country in 2021

Figure 34. Americas Imipenem API Revenue Market Share by Country in 2021

Figure 35. United States Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Imipenem API Sales Market Share by Region in 2021

Figure 40. APAC Imipenem API Revenue Market Share by Regions in 2021

Figure 41. China Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Imipenem API Sales Market Share by Country in 2021

Figure 48. Europe Imipenem API Revenue Market Share by Country in 2021

Figure 49. Germany Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Imipenem API Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Imipenem API Revenue Market Share by Country in 2021

Figure 56. Egypt Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Imipenem API Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Imipenem API in 2021

Figure 62. Manufacturing Process Analysis of Imipenem API

Figure 63. Industry Chain Structure of Imipenem API

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390